199 related articles for article (PubMed ID: 24282281)
21. IL-6 signaling promotes tumor growth in colorectal cancer.
Becker C; Fantini MC; Wirtz S; Nikolaev A; Lehr HA; Galle PR; Rose-John S; Neurath MF
Cell Cycle; 2005 Feb; 4(2):217-20. PubMed ID: 15655344
[TBL] [Abstract][Full Text] [Related]
22. CTGF mediates Smad-dependent transforming growth factor β signaling to regulate mesenchymal cell proliferation during palate development.
Parada C; Li J; Iwata J; Suzuki A; Chai Y
Mol Cell Biol; 2013 Sep; 33(17):3482-93. PubMed ID: 23816882
[TBL] [Abstract][Full Text] [Related]
23. Epithelial-macrophage interactions determine pulmonary fibrosis susceptibility in Hermansky-Pudlak syndrome.
Young LR; Gulleman PM; Short CW; Tanjore H; Sherrill T; Qi A; McBride AP; Zaynagetdinov R; Benjamin JT; Lawson WE; Novitskiy SV; Blackwell TS
JCI Insight; 2016 Oct; 1(17):e88947. PubMed ID: 27777976
[TBL] [Abstract][Full Text] [Related]
24. CCR2
Lebrun A; Lo Re S; Chantry M; Izquierdo Carerra X; Uwambayinema F; Ricci D; Devosse R; Ibouraadaten S; Brombin L; Palmai-Pallag M; Yakoub Y; Pasparakis M; Lison D; Huaux F
J Pathol; 2017 Nov; 243(3):320-330. PubMed ID: 28799208
[TBL] [Abstract][Full Text] [Related]
25. Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis.
Meng X; Vander Ark A; Lee P; Hostetter G; Bhowmick NA; Matrisian LM; Williams BO; Miranti CK; Li X
Oncogene; 2016 May; 35(18):2370-8. PubMed ID: 26279296
[TBL] [Abstract][Full Text] [Related]
26. Mesodermal deletion of transforming growth factor-beta receptor II disrupts lung epithelial morphogenesis: cross-talk between TGF-beta and Sonic hedgehog pathways.
Li M; Li C; Liu YH; Xing Y; Hu L; Borok Z; Kwong KY; Minoo P
J Biol Chem; 2008 Dec; 283(52):36257-64. PubMed ID: 18990706
[TBL] [Abstract][Full Text] [Related]
27. Obesity triggers enhanced MDSC accumulation in murine renal tumors via elevated local production of CCL2.
Hale M; Itani F; Buchta CM; Wald G; Bing M; Norian LA
PLoS One; 2015; 10(3):e0118784. PubMed ID: 25769110
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor β induces bone marrow mesenchymal stem cell migration via noncanonical signals and N-cadherin.
Dubon MJ; Yu J; Choi S; Park KS
J Cell Physiol; 2018 Jan; 233(1):201-213. PubMed ID: 28213973
[TBL] [Abstract][Full Text] [Related]
29. Modulation of lipid metabolic defects rescues cleft palate in Tgfbr2 mutant mice.
Iwata J; Suzuki A; Pelikan RC; Ho TV; Sanchez-Lara PA; Chai Y
Hum Mol Genet; 2014 Jan; 23(1):182-93. PubMed ID: 23975680
[TBL] [Abstract][Full Text] [Related]
30. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development.
Amendt C; Schirmacher P; Weber H; Blessing M
Oncogene; 1998 Jul; 17(1):25-34. PubMed ID: 9671311
[TBL] [Abstract][Full Text] [Related]
31. Schlafen 4-expressing myeloid-derived suppressor cells are induced during murine gastric metaplasia.
Ding L; Hayes MM; Photenhauer A; Eaton KA; Li Q; Ocadiz-Ruiz R; Merchant JL
J Clin Invest; 2016 Aug; 126(8):2867-80. PubMed ID: 27427984
[TBL] [Abstract][Full Text] [Related]
32. Properties of immature myeloid progenitors with nitric-oxide-dependent immunosuppressive activity isolated from bone marrow of tumor-free mice.
Forghani P; Harris W; Giver CR; Mirshafiey A; Galipeau J; Waller EK
PLoS One; 2013; 8(7):e64837. PubMed ID: 23843936
[TBL] [Abstract][Full Text] [Related]
33. TGF-beta type I receptor Alk5 regulates tooth initiation and mandible patterning in a type II receptor-independent manner.
Zhao H; Oka K; Bringas P; Kaartinen V; Chai Y
Dev Biol; 2008 Aug; 320(1):19-29. PubMed ID: 18572160
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
Wendt MK; Schiemann WP
Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
[TBL] [Abstract][Full Text] [Related]
35. Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells.
Bodogai M; Moritoh K; Lee-Chang C; Hollander CM; Sherman-Baust CA; Wersto RP; Araki Y; Miyoshi I; Yang L; Trinchieri G; Biragyn A
Cancer Res; 2015 Sep; 75(17):3456-65. PubMed ID: 26183924
[TBL] [Abstract][Full Text] [Related]
36. SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes.
Kocic J; Bugarski D; Santibanez JF
Eur J Cancer; 2012 Jul; 48(10):1550-7. PubMed ID: 21798735
[TBL] [Abstract][Full Text] [Related]
37. Concordant repression and aberrant methylation of transforming growth factor-beta signaling pathway genes occurs early in gastric cardia adenocarcinoma.
Guo W; Dong Z; Guo Y; Kuang G; Yang Z; Shan B
Mol Biol Rep; 2012 Oct; 39(10):9453-62. PubMed ID: 22722999
[TBL] [Abstract][Full Text] [Related]
38. Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.
Rhodes SD; Wu X; He Y; Chen S; Yang H; Staser KW; Wang J; Zhang P; Jiang C; Yokota H; Dong R; Peng X; Yang X; Murthy S; Azhar M; Mohammad KS; Xu M; Guise TA; Yang FC
J Bone Miner Res; 2013 Dec; 28(12):2476-89. PubMed ID: 23703870
[TBL] [Abstract][Full Text] [Related]
39. Monocytic MDSC as a source of immunosuppressive cytokines in chronic lymphocytic leukemia (CLL) microenvironment.
Kowalska W; Bojarska-Junak A
Folia Histochem Cytobiol; 2020; 58(1):25-36. PubMed ID: 32227331
[TBL] [Abstract][Full Text] [Related]
40. LDK378 inhibits the recruitment of myeloid-derived suppressor cells to spleen via the p38-GRK2-CCR2 pathway in mice with sepsis.
Hu J; Zhang W; Liu Y; Yang Y; Tan C; Wei X; Wang Y; Tan S; Liu M; Liu K; Liu Y; Zhang H; Xiao X
Immunol Cell Biol; 2019 Nov; 97(10):902-915. PubMed ID: 31472096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
